Agios Pharmaceuticals Inc AGIO

NAS: AGIO | ISIN: US00847X1046 13/11/2025

42,54 USD (-2,50%)

(-2,50%) 13/11/2025

Toon enkel gratis nieuws

12 april 2023 · Totus Medicines Expands its Scientific Advisory Board with the Addition of Dr. Lewis Cantley, Dr. Hope Rugo, and Dr. Josep Tabernero · Persbericht

18 maart 2021 · Agios Sponsors Program Promoting Health Literacy for Patients with Sickle Cell Disease · Persbericht

26 februari 2021 · Agios Recognizes 14th Annual Rare Disease Day and Raises Awareness of Unmet Needs in Rare Hemolytic Anemias · Persbericht

25 februari 2021 · Agios Reports Fourth Quarter and Full Year 2020 Financial Results · Persbericht

23 februari 2021 · Agios to Present at March Investor Conferences · Persbericht

26 januari 2021 · Agios Announces Phase 3 ACTIVATE-T Trial of Mitapivat Achieved Primary Endpoint in Adults with Pyruvate Kinase Deficiency Who Are Regularly Transfused · Persbericht

17 januari 2021 · Agios Presents Final Data from Phase 3 ClarIDHy Study of TIBSOVO® (ivosidenib tablets) in Patients with Previously Treated IDH1-Mutant Cholangiocarcinoma · Persbericht

11 januari 2021 · Agios Highlights 2021 Milestones to Accelerate and Expand Its Genetically Defined Disease Portfolio and Drive Near- and Long-Term Value Creation · Persbericht

5 januari 2021 · Agios to Present at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe